Anticancer activity of a series of copper(II) complexes with tripodal ligands
European Journal of Medicinal Chemistry, ISSN: 0223-5234, Vol: 132, Page: 274-281
2017
- 65Citations
- 61Captures
Metric Options: Counts1 Year3 YearSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations65
- Citation Indexes64
- 64
- CrossRef59
- Patent Family Citations1
- Patent Families1
- Captures61
- Readers61
- 61
Article Description
A series of copper(II) complexes with tripodal polypyridylamine ligands (derived from the parent ligand tris(2-pyridylmethyl)amine, tmpa) has been synthesized. Crystallographic characterization was possible for all complexes obtained. The copper(II) chloride complexes were investigated for their in vitro anticancer potential using human tumor cell lines containing examples of cervical, colon, ovarian cancers and melanoma. Some compounds showed a similar activity compared to that of cisplatin, however no systematic behavior could be observed.
Bibliographic Details
http://www.sciencedirect.com/science/article/pii/S0223523417301769; http://dx.doi.org/10.1016/j.ejmech.2017.03.019; http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85016483674&origin=inward; http://www.ncbi.nlm.nih.gov/pubmed/28371639; https://linkinghub.elsevier.com/retrieve/pii/S0223523417301769; https://dx.doi.org/10.1016/j.ejmech.2017.03.019
Elsevier BV
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know